View More Recent Stories
-
H.C. Wainwright Reiterates Buy Rating on Arcturus Therapeutics (ARCT)
-
Arcturus Therapeutics (ARCT) Provides Updates for Ornithine Transcarbamylase (OTC) Deficiency and Cystic Fibrosis (CF) Programs
-
Arcturus Therapeutics (ARCT) Appoints Moncef Slaoui to its Board
